SCHEMBL3454044

SCHEMBL3454044

C1=CC2=NC1=CC1=NC(=C(c3ccncc3)C3=NC(=CC4=NC(=C2)C=C4)C=C3c2ccncc2)C(c2ccncc2)=C1c1ccncc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11344532 0.99 — —
SCHEMBL7165138 0.87 — —
SCHEMBL28518152 0.87 — —
SCHEMBL28026975 0.87 — —
Hydrochloric Acid SCHEMBL3190944 0.87 — —
SCHEMBL11869329 0.87 — —
SCHEMBL16440032 0.87 — —
SCHEMBL28599777 0.87 — —
SCHEMBL37860 0.87 — —
Water SCHEMBL28237488 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230218663-A1 COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION THE UNIVERSITY OF HONG KONG (CN) 2023-07-13 — — US claimed
US-8501366-B1 Nanoengineered membrane electrode assembly interface SANDIA CORPORATION (US) 2013-08-06 — — US claimed
US-8324342-B1 Porphyrin coordination polymer nanospheres and nanorods SANDIA CORPORATION (US) 2012-12-04 — — US claimed
EP-0222167-A2 Process for the catalytic epoxidation of olefines with hydrogen peroxide Degussa Aktiengesellschaft (DE) 1987-05-20 — — EP claimed
US-12503562-B1 Composite particle and use thereof in optical filtration COLOURSMITH LABS INC. (CA) 2025-12-23 — — US disclosed
US-20250108036-A1 COMPOSITIONS FOR REMOVING SENESCENT CELLS AND USES THEREOF LIFECEUTIX CO., LTD. (KR) 2025-04-03 — — US disclosed
US-20230218663-A1 COMPOSITIONS AND METHODS FOR TREATING A SARS-COV-2 INFECTION THE UNIVERSITY OF HONG KONG (CN) 2023-07-13 — — US disclosed
US-11287433-B2 Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptoms and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s) INSTITUT PASTEUR (FR) 2022-03-29 — — US disclosed
EP-3105596-B1 METHODS FOR IN VITRO INVESTIGATING MITOCHONDRIAL REPLICATION DYSFUNCTION IN A BIOLOGICAL SAMPLE, KITS AND USES THEREOF, THERAPEUTIC METHODS AGAINST PROGEROID-LIKE SYNDROMES OR SYMPTOMES AND SCREENING METHOD FOR IDENTIFYING PARTICULAR PROTEASE INHIBITOR(S) AND/OR NITROSO-REDOX STRESS SCAVENGER COMPOUND(S) PASTEUR INSTITUT (FR) 2020-05-27 — — EP disclosed
US-20200049718-A1 METHODS FOR IN VITRO INVESTIGATING MITOCHONDRIAL REPLICATION DYSFUNCTION IN A BIOLOGICAL SAMPLE, KITS AND USES THEREOF, THERAPEUTIC METHODS AGAINST PROGEROID-LIKE SYNDROMES OR SYMPTOMES AND SCREENING METHOD FOR IDENTIFYING PARTICULAR PROTEASE INHIBITOR(S) AND/OR NITROSO-REDOX STRESS SCAVENGER COMPOUND(S) PASTEUR INSTITUT (FR) 2020-02-13 — — US disclosed
US-10338082-B2 Methods for in vitro investigating mitochondrial replication dysfunction in a biological sample, kits and uses thereof, therapeutic methods against progeroid-like syndromes or symptomes and screening method for identifying particular protease inhibitor(s) and/or nitroso-redox stress scavenger compound(s) INSTITUT PASTEUR (FR) 2019-07-02 — — US disclosed
EP-3471774-A1 PORPHYRIN COMPOUNDS AND COMPOSITIONS USEFUL FOR TREATING CANCER Oncoselect Therapeutics, LLC (US) 2019-04-24 — — EP disclosed
WO-2000027379-A2 PHARMACEUTICAL COMPOSITIONS COMPRISING PORPHYRINS AND SOME NOVEL PORPHYRIN DERIVATIVES YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) 2000-05-18 — — WO disclosed
EP-0283753-B1 PROCESS FOR THE CATALYTIC EPOXIDATION OF OLEFINS WITH HYDROGEN PEROXIDE Degussa Aktiengesellschaft (DE) 1990-09-19 — — EP disclosed
EP-0308791-A1 Process for the catalytic epoxydation of olefins with hydrogen peroxide Degussa Aktiengesellschaft (DE) 1989-03-29 — — EP disclosed
EP-0222167-A3 PROCESS FOR THE CATALYTIC EPOXIDATION OF OLEFINES WITH HYDROGEN PEROXIDE Degussa Aktiengesellschaft (DE) 1988-05-18 — — EP disclosed
EP-0222167-A2 Process for the catalytic epoxidation of olefines with hydrogen peroxide Degussa Aktiengesellschaft (DE) 1987-05-20 — — EP disclosed
US-4255273-A COMPRISING A WATER-SOLUBLE PHOTOACTIVATOR AND A CATIONIC SUBSTANCE THE PROCTER & GAMBLE COMPANY (US) 1981-03-10 — — US disclosed
EP-0003371-A1 Composition containing a cationic substance and a photoactivator for improved washing and bleaching of fabrics THE PROCTER &amp; GAMBLE COMPANY (US) 1979-08-08 — — EP disclosed
US-4090877-A COLOR PHOTOGRAPHY MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1978-05-23 — — US disclosed
Send feedback